432 filings
Page 6 of 22
8-K
qip4f gla5d4zfxqeh0
15 Apr 21
Other Events
12:00am
8-K
s7lqn3pi9i00pv ugp
8 Mar 21
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
4:01pm
8-K
ujak8c3x 83k
3 Mar 21
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year
4:01pm
EFFECT
xpwg47hgr wwzog7puv
10 Feb 21
Notice of effectiveness
12:15am
8-K
yql 76sdygqrb1hj4p
5 Feb 21
Soleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi Syndrome
8:01am
CORRESP
cuo1p lzywwfy2yg3
5 Feb 21
Correspondence with SEC
12:00am
CORRESP
r3j 9sjp4486v
2 Feb 21
Correspondence with SEC
12:00am
UPLOAD
e4hfz3q74ph9 zx
28 Jan 21
Letter from SEC
12:00am
8-K
rbeeov3if
13 Jan 21
Departure of Directors or Certain Officers
4:05pm
S-8
f4k1kng3v9ut08s6vxg
11 Jan 21
Registration of securities for employees
4:27pm
8-K
g66yqt
11 Dec 20
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
8:31am
8-K
o6i xpnmi
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
dhb79ok2 nn
10 Nov 20
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results
4:22pm
8-K
lc9n ynlcbj5
2 Oct 20
Departure of Directors or Certain Officers
4:49pm
8-K
yljmaoyqp3ob0 x0fj
10 Aug 20
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:09pm